Literature DB >> 20921391

SNARE tagging allows stepwise assembly of a multimodular medicinal toxin.

Frédéric Darios1, Dhevahi Niranjan, Enrico Ferrari, Fan Zhang, Mikhail Soloviev, Andreas Rummel, Hans Bigalke, Jason Suckling, Yuri Ushkaryov, Nikolay Naumenko, Anastasia Shakirzyanova, Rashid Giniatullin, Elizabeth Maywood, Michael Hastings, Thomas Binz, Bazbek Davletov.   

Abstract

Generation of supramolecular architectures through controlled linking of suitable building blocks can offer new perspectives to medicine and applied technologies. Current linking strategies often rely on chemical methods that have limitations and cannot take full advantage of the recombinant technologies. Here we used SNARE proteins, namely, syntaxin, SNAP25, and synaptobrevin, which form stable tetrahelical complexes that drive fusion of intracellular membranes, as versatile tags for irreversible linking of recombinant and synthetic functional units. We show that SNARE tagging allows stepwise production of a functional modular medicinal toxin, namely, botulinum neurotoxin type A, commonly known as BOTOX. This toxin consists of three structurally independent units: Receptor-binding domain (Rbd), Translocation domain (Td), and the Light chain (Lc), the last being a proteolytic enzyme. Fusing the receptor-binding domain with synaptobrevin SNARE motif allowed delivery of the active part of botulinum neurotoxin (Lc-Td), tagged with SNAP25, into neurons. Our data show that SNARE-tagged toxin was able to cleave its intraneuronal molecular target and to inhibit release of neurotransmitters. The reassembled toxin provides a safer alternative to existing botulinum neurotoxin and may offer wider use of this popular research and medical tool. Finally, SNARE tagging allowed the Rbd portion of the toxin to be used to deliver quantum dots and other fluorescent markers into neurons, showing versatility of this unique tagging and self-assembly technique. Together, these results demonstrate that the SNARE tetrahelical coiled-coil allows controlled linking of various building blocks into multifunctional assemblies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921391      PMCID: PMC2964210          DOI: 10.1073/pnas.1007125107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  Fabrication of novel biomaterials through molecular self-assembly.

Authors:  Shuguang Zhang
Journal:  Nat Biotechnol       Date:  2003-10       Impact factor: 54.908

Review 2.  Botulinum toxin in clinical practice.

Authors:  J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

Review 3.  Botulinum neurotoxin: a marvel of protein design.

Authors:  Mauricio Montal
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

Review 4.  Engineered toxins: new therapeutics.

Authors:  Keith A Foster
Journal:  Toxicon       Date:  2009-03-03       Impact factor: 3.033

5.  Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution.

Authors:  R B Sutton; D Fasshauer; R Jahn; A T Brunger
Journal:  Nature       Date:  1998-09-24       Impact factor: 49.962

6.  Crystal structure of botulinum neurotoxin type A and implications for toxicity.

Authors:  D B Lacy; W Tepp; A C Cohen; B R DasGupta; R C Stevens
Journal:  Nat Struct Biol       Date:  1998-10

7.  Identification of a minimal core of the synaptic SNARE complex sufficient for reversible assembly and disassembly.

Authors:  D Fasshauer; W K Eliason; A T Brünger; R Jahn
Journal:  Biochemistry       Date:  1998-07-21       Impact factor: 3.162

8.  Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.

Authors:  L L Simpson; J A Coffield; N Bakry
Journal:  J Pharmacol Exp Ther       Date:  1994-04       Impact factor: 4.030

9.  SNAP receptors implicated in vesicle targeting and fusion.

Authors:  T Söllner; S W Whiteheart; M Brunner; H Erdjument-Bromage; S Geromanos; P Tempst; J E Rothman
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

10.  Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly.

Authors:  T Hayashi; H McMahon; S Yamasaki; T Binz; Y Hata; T C Südhof; H Niemann
Journal:  EMBO J       Date:  1994-11-01       Impact factor: 11.598

View more
  22 in total

1.  Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism.

Authors:  Callista B Harper; Sally Martin; Tam H Nguyen; Shari J Daniels; Nickolas A Lavidis; Michel R Popoff; Gordana Hadzic; Anna Mariana; Ngoc Chau; Adam McCluskey; Phillip J Robinson; Frederic A Meunier
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

2.  Novel Native and Engineered Botulinum Neurotoxins.

Authors:  Lance Steward; Mitchell F Brin; Amy Brideau-Andersen
Journal:  Handb Exp Pharmacol       Date:  2021

3.  Interactions between nociceptor sensory neurons and microbial pathogens in pain.

Authors:  Larissa Staurengo-Ferrari; Liwen Deng; Isaac M Chiu
Journal:  Pain       Date:  2022-11-01       Impact factor: 7.926

4.  Conjugated Quantum Dots Inhibit the Amyloid β (1-42) Fibrillation Process.

Authors:  Garima Thakur; Miodrag Micic; Yuehai Yang; Wenzhi Li; Dania Movia; Silvia Giordani; Hongzhou Zhang; Roger M Leblanc
Journal:  Int J Alzheimers Dis       Date:  2011-03-02

Review 5.  Towards new uses of botulinum toxin as a novel therapeutic tool.

Authors:  Andy Pickett; Karen Perrow
Journal:  Toxins (Basel)       Date:  2011-01-12       Impact factor: 4.546

6.  Re-assembled botulinum neurotoxin inhibits CNS functions without systemic toxicity.

Authors:  Enrico Ferrari; Elizabeth S Maywood; Laura Restani; Matteo Caleo; Marco Pirazzini; Ornella Rossetto; Michael H Hastings; Dhevahi Niranjan; Giampietro Schiavo; Bazbek Davletov
Journal:  Toxins (Basel)       Date:  2011-03-24       Impact factor: 4.546

7.  Assembly of protein building blocks using a short synthetic peptide.

Authors:  Enrico Ferrari; Mikhail Soloviev; Dhevahi Niranjan; Jason Arsenault; Chunjing Gu; Yvonne Vallis; John O'Brien; Bazbek Davletov
Journal:  Bioconjug Chem       Date:  2012-02-10       Impact factor: 4.774

8.  Sigma-1 receptor expression in the dorsal root ganglion: Reexamination using a highly specific antibody.

Authors:  Timur A Mavlyutov; Tyler Duellman; Hung Tae Kim; Miles L Epstein; Charlotte Leese; Bazbek A Davletov; Jay Yang
Journal:  Neuroscience       Date:  2016-06-23       Impact factor: 3.590

9.  Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine.

Authors:  Anna P Andreou; Charlotte Leese; Rosaria Greco; Chiara Demartini; Eve Corrie; Deniz Simsek; Anna Zanaboni; Ksenia Koroleva; Joseph O Lloyd; Giorgio Lambru; Ciara Doran; Oleg Gafurov; Elizabeth Seward; Rashid Giniatullin; Cristina Tassorelli; Bazbek Davletov
Journal:  Neurotherapeutics       Date:  2020-11-17       Impact factor: 7.620

10.  Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain.

Authors:  Changchun Chen; Shuhui Wang; Huajing Wang; Xiaoyan Mao; Tiancheng Zhang; Guanghui Ji; Xin Shi; Tian Xia; Weijia Lu; Dapeng Zhang; Jianxin Dai; Yajun Guo
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.